Health care consumers, and news consumers, are often not told of the biases that may exist in medical research, in clinical care, or in health care professionals’ continuing medical education because of financial ties to drug companies and medical device manufacturers. Journalists, broadcasters, editors, and producers too often rely – wittingly or unwittingly – on [...]
Journalistic hype of health news never stops. The latest: ABC News last week called the drug Dimebon a “miracle drug” for Alzheimer’s Disease on its website. It was tested in about 100 people. It was only tested against placebo, not head-to-head with any other existing Alzheimer’s treatment. ABC News didn’t interview the principal investigator in [...]
Recently a physician friend brought the following to my attention. The same story, written by the same person, but appearing under two very different headlines. Here’s the original New York Times headline: The story stated at one point: “No one knows whether vaccinations had anything to do with the girls’ health problems, and the scientific [...]
In case you don’t visit the HealthNewsReview.org site often, I wanted to let you know about a new Publisher’s Note just published there. It reads: Our database of stories reviewed now numbers more than 600. 113 of the stories were by the Associated Press, which feeds most newsrooms. We’ve reviewed 38 stories by the Los [...]
We look for more critical analysis of FDA expedited approval of a new drug like this.
Five-star story on small study that tries to counter large body of evidence on soy supplements for hot flashes.
Our reviewers, including a leading women’s health clinician-researcher, felt this piece would have been benefited from more data and context.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2012 Health News Review
